Serveur d'exploration sur les relations entre la France et l'Australie - Corpus (PubMed)

Index « MedMesh.i » - entrée « Polyethylene Glycols »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Polyesters < Polyethylene Glycols < Polyketides  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
001019 (2017) Mark S. Sulkowski ; Walford J. Fessel ; Adriano Lazzarin ; Juan Berenguer ; Natalia Zakharova ; Hugo Cheinquer ; Pierre Côté ; Douglas Dieterich ; Adrian Gadano ; Gail Matthews ; Jean-Michel Molina ; Christophe Moreno ; Juan Antonio Pineda ; Federico Pulido ; Antonio Rivero ; Jurgen Rockstroh ; Dennis Hernandez ; Fiona Mcphee ; Timothy Eley ; Zhaohui Liu ; Patricia Mendez ; Eric Hughes ; Stephanie Noviello ; Peter AckermanEfficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study.
001250 (2017) Roberto Sorio ; Célia Roemer-Becuwe ; Felix Hilpert ; Emma Gibbs ; Yolanda García ; Janne Kaern ; Manon Huizing ; Petronella Witteveen ; Flora Zagouri ; David Coeffic ; Hans-Joachim Lück ; Antonio González-Martín ; Gunnar Kristensen ; Charles-Briac Levaché ; Chee Khoon Lee ; Val Gebski ; Eric Pujade-LauraineSafety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.
001689 (2016) P. Marcellin ; S H Ahn ; W-L Chuang ; A J Hui ; F. Tabak ; R. Mehta ; J. Petersen ; C-M Lee ; X. Ma ; F A Caruntu ; W Y Tak ; M. Elkhashab ; L. Lin ; G. Wu ; E B Martins ; P. Charuworn ; L J Yee ; S G Lim ; G R Foster ; S. Fung ; L. Morano ; D. Samuel ; K. Agarwal ; R. Idilman ; S I Strasser ; M. Buti ; G B Gaeta ; G. Papatheodoridis ; R. Flisiak ; H L Y. ChanPredictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.
002049 (2016) Francesco Locatelli ; Gabriel Choukroun ; Matt Truman ; Alfons Wiggenhauser ; Danilo FliserOnce-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials.
002176 (2016) Tarik Asselah ; Alex J. Thompson ; Robert Flisiak ; Manuel Romero-Gomez ; Diethelm Messinger ; Georgios Bakalos ; Mitchell L. ShiffmanA Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.
002392 (2016) Thierry Moser ; Coralie Celma ; Audrey Lebert ; Eric Charrault ; Robert Brooke ; Peter J. Murphy ; Gareth Browne ; Richard Young ; Timothy Higgs ; Drew EvansHydrophilic Organic Electrodes on Flexible Hydrogels.
002538 (2016) Maria Luisa Montes ; Mark Nelson ; Pierre-Marie Girard ; Joe Sasadeusz ; Andrzej Horban ; Beatriz Grinsztejn ; Natalia Zakharova ; Antonio Rivero ; Jacques Durant ; Enrique Ortega-Gonzalez ; Erkki Lathouwers ; Katrien Janssen ; Sivi Ouwerkerk-Mahadevan ; James Witek ; Juan González-GarcíaTelaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study.
002545 (2016) Patrick Marcellin ; Sang Hoon Ahn ; Xiaoli Ma ; Florin A. Caruntu ; Won Young Tak ; Magdy Elkashab ; Wan-Long Chuang ; Seng-Gee Lim ; Fehmi Tabak ; Rajiv Mehta ; Joerg Petersen ; Graham R. Foster ; Lillian Lou ; Eduardo B. Martins ; Phillip Dinh ; Lanjia Lin ; Amoreena Corsa ; Prista Charuworn ; G Mani Subramanian ; Hans Reiser ; Hendrick W. Reesink ; Scott Fung ; Simone I. Strasser ; Huy Trinh ; Maria Buti ; Giovanni B. Gaeta ; Aric J. Hui ; George Papatheodoridis ; Robert Flisiak ; Henry L Y. ChanCombination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.
002C95 (2015) Christophe Hézode ; Gideon M. Hirschfield ; Wayne Ghesquiere ; William Sievert ; Maribel Rodriguez-Torres ; Stephen D. Shafran ; Paul J. Thuluvath ; Harvey A. Tatum ; Imam Waked ; Gamal Esmat ; Eric J. Lawitz ; Vinod K. Rustgi ; Stanislas Pol ; Nina Weis ; Paul J. Pockros ; Marc Bourlière ; Lawrence Serfaty ; John M. Vierling ; Michael W. Fried ; Ola Weiland ; Maurizia R. Brunetto ; Gregory T. Everson ; Stefan Zeuzem ; Paul Y. Kwo ; Mark Sulkowski ; Norbert Br U ; Dennis Hernandez ; Fiona Mcphee ; Megan Wind-Rotolo ; Zhaohui Liu ; Stephanie Noviello ; Eric A. Hughes ; Philip D. Yin ; Steven SchnittmanDaclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
002F25 (2015) Andrew Wildes ; Liya Khadeeva ; William Trewby ; Jessica Valle-Orero ; Andrew Studer ; Jean-Luc Garden ; Michel PeyrardMelting of highly oriented fiber DNA subjected to osmotic pressure.
002F88 (2015) Eric Lawitz ; Edward Gane ; Brian Pearlman ; Edward Tam ; Wayne Ghesquiere ; Dominique Guyader ; Laurent Alric ; Jean-Pierre Bronowicki ; Laura Lester ; William Sievert ; Reem Ghalib ; Luis Balart ; Fredrik Sund ; Martin Lagging ; Frank Dutko ; Melissa Shaughnessy ; Peggy Hwang ; Anita Y M. Howe ; Janice Wahl ; Michael Robertson ; Eliav Barr ; Barbara HaberEfficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.
003020 (2015) Sven Mahner ; Werner Meier ; Andreas Du Bois ; Chris Brown ; Domenica Lorusso ; Tiziana Dell'Anna ; Jacques Cretin ; Hanne Havsteen ; Paul Bessette ; Alain G. Zeimet ; Ignace Vergote ; Paul Vasey ; Eric Pujade-Lauraine ; Laurence Gladieff ; Annamaria FerreroCarboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
003078 (2015) Gregory J. Dore ; Eric Lawitz ; Christophe Hézode ; Stephen D. Shafran ; Alnoor Ramji ; Harvey A. Tatum ; Gloria Taliani ; Albert Tran ; Maurizia R. Brunetto ; Serena Zaltron ; Simone I. Strasser ; Nina Weis ; Wayne Ghesquiere ; Samuel S. Lee ; Dominique Larrey ; Stanislas Pol ; Hugh Harley ; Jacob George ; Scott K. Fung ; Victor De Lédinghen ; Peggy Hagens ; Fiona Mcphee ; Dennis Hernandez ; David Cohen ; Elizabeth Cooney ; Stephanie Noviello ; Eric A. HughesDaclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.
003121 (2015) K Rajender Reddy ; Stefan Zeuzem ; Fabien Zoulim ; Ola Weiland ; Andrzej Horban ; Carol Stanciu ; Federico Guillermo Villamil ; Pietro Andreone ; Jacob George ; Elisabeth Dammers ; Min Fu ; Darryl Kurland ; Oliver Lenz ; Sivi Ouwerkerk-Mahadevan ; Thierry Verbinnen ; Jane Scott ; Wolfgang JessnerSimeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial.
003138 (2015) Chee Khoon Lee ; Sarah Lord ; Tami Grunewald ; Val Gebski ; Anne-Claire Hardy-Bessard ; Jalid Sehouli ; Kathrine Woie ; Mark Heywood ; Christian Schauer ; Ignace Vergote ; Giovanni Scambia ; Annamaria Ferrero ; Philipp Harter ; Eric Pujade-Lauraine ; Michael FriedlanderImpact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial.
003361 (2014) Massimo Colombo ; Simone Strasser ; Christophe Moreno ; Paulo Abrao Ferreira ; Petr Urbanek ; Inmaculada Fernández ; Djamal Abdurakmonov ; Adrian Streinu-Cercel ; Anke Verheyen ; Wafae Iraqi ; Ralph Demasi ; Andrew Hill ; Isabelle Lonjon-Domanec ; Heiner WedemeyerSustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program.
003633 (2014) M. Colombo ; I. Fernández ; D. Abdurakhmanov ; P A Ferreira ; S I Strasser ; P. Urbanek ; C. Moreno ; A. Streinu-Cercel ; A. Verheyen ; W. Iraqi ; R. Demasi ; A. Hill ; J M L Uffer ; I. Lonjon-Domanec ; H. WedemeyerSafety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.
003780 (2014) Martin R. Stockler ; Felix Hilpert ; Michael Friedlander ; Madeleine T. King ; Lari Wenzel ; Chee Khoon Lee ; Florence Joly ; Nikolaus De Gregorio ; José Angel Arranz ; Mansoor Raza Mirza ; Roberto Sorio ; Ulrich Freudensprung ; Vesna Sneller ; Gill Hales ; Eric Pujade-LaurainePatient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.
003895 (2014) Maria Buti ; Kosh Agarwal ; Yves Horsmans ; William Sievert ; Ewa Janczewska ; Stefan Zeuzem ; Lisa Nyberg ; Robert S. Brown ; Christophe Hézode ; Mario Rizzetto ; Raymundo Paraná ; Sandra De Meyer ; Ralph De Masi ; Donghan Luo ; Kirk Bertelsen ; James WitekTelaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Polyethylene Glycols" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Polyethylene Glycols" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Polyethylene Glycols
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024